Struma ovarii other diagnostic studies: Difference between revisions
Usama Talib (talk | contribs) Created page with "__NOTOC__ {{Stroma of ovary}} {{CMG}}; {{AE}} ==Overview== *There are no other diagnostic studies associated with [disease name]. *[Diagnostic study] may be helpful in the..." |
No edit summary |
||
(5 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{Struma ovarii}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} | ||
==Overview== | ==Overview== | ||
Radiological findings, ascites and raised CA-125 levels make it a unique and highly suspicious case of malignancy. Histopathologic studies may aid in diagnosing the malignant struma ovarii when there is no evidence of clinical malignancy or metastases. | |||
==Other Diagnostic Studies== | ==Other Diagnostic Studies== | ||
Radiological findings, ascites and raised CA-125 levels make it a unique and highly suspicious case of malignancy. | |||
Histopathologic studies may aid in diagnosing the malignant struma ovarii when there is no evidence of clinical malignancy or metastases. | |||
==References== | ==References== |
Latest revision as of 00:38, 16 October 2017
Struma ovarii Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Struma ovarii other diagnostic studies On the Web |
American Roentgen Ray Society Images of Struma ovarii other diagnostic studies |
Risk calculators and risk factors for Struma ovarii other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Radiological findings, ascites and raised CA-125 levels make it a unique and highly suspicious case of malignancy. Histopathologic studies may aid in diagnosing the malignant struma ovarii when there is no evidence of clinical malignancy or metastases.
Other Diagnostic Studies
Radiological findings, ascites and raised CA-125 levels make it a unique and highly suspicious case of malignancy. Histopathologic studies may aid in diagnosing the malignant struma ovarii when there is no evidence of clinical malignancy or metastases.